Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Cogent Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- +28 vs. Q1 2022
- Shares held
- 70.3M
- +23.1M (+49.0%) vs. Q1 2022
- Total value
- $633.3M
- +$280.0M (+79.2%) vs. Q1 2022
- New holders
- 41
- 43 more added
- Sold out
- 13
- 18 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COGT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $7.50B |
| Q1 2026 | 305 | $7.17B |
| Q4 2025 | 267 | $6.18B |
| Q3 2025 | 195 | $2.29B |
| Q2 2025 | 181 | $973.2M |
| Q1 2025 | 186 | $799.6M |
| Q4 2024 | 177 | $949.5M |
| Q3 2024 | 161 | $1.32B |
| Q2 2024 | 149 | $1.02B |
| Q1 2024 | 146 | $734.3M |
| Q4 2023 | 144 | $534.0M |
| Q3 2023 | 135 | $885.8M |
| Q2 2023 | 136 | $1.05B |
| Q1 2023 | 137 | $810.4M |
| Q4 2022 | 135 | $864.1M |
| Q3 2022 | 134 | $1.10B |
| Q2 2022 | 112 | $633.3M |
| Q1 2022 | 86 | $353.6M |
| Q4 2021 | 82 | $385.2M |
| Q3 2021 | 73 | $309.6M |
| Q2 2021 | 69 | $293.7M |
| Q1 2021 | 69 | $303.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Cogent Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 2,094,154 | $18.9M | 1.78% | −557,600−21.0% | Reduced |
| Janus Henderson Group PLC | 2,130,496 | $19.2M | 0.01% | −1,034,745−32.7% | Reduced |
| BVF Inc | 2,257,174 | $20.4M | 0.98% | +724,892+47.3% | Added |
| Vanguard Group Inc | 2,585,804 | $23.3M | 0.00% | +942,835+57.4% | Added |
| Fairmount Funds Management LLC | 2,758,975 | $24.9M | 5.70% | +1,200,000+77.0% | Added |
| Perceptive Advisors LLC | 3,088,972 | $27.9M | 0.88% | −99,778−3.1% | Reduced |
| BlackRock Inc. | 3,296,780 | $29.7M | 0.00% | +657,409+24.9% | Added |
| TCG Crossover Management, LLC | 3,481,042 | $31.4M | 13.34% | +500,000+16.8% | Added |
| VR Adviser, LLC | 4,038,117 | $36.4M | 7.17% | +2,949,300+270.9% | Added |
| Commodore Capital LP | 4,944,708 | $44.6M | 9.43% | +1,443,940+41.2% | Added |
| Eventide Asset Management, LLC | 5,095,000 | $46.0M | 0.98% | +1,195,000+30.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 5,876,805 | $53.0M | 1.12% | +4,275,805+267.1% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −853,451−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −223,554−100.0% | Sold out |
| Atlas Venture Life Science Advisors, LLC | 0 | $0 | 0.00% | −186,487−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −36,783−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −19,452−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,101−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −666−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −799−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −282−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −129−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |